Prominent publications by Emmanuel Mahé

KOL Index score: 16304

BACKGROUND: Scabies is a frequent condition seen in infants and children. Only topical treatments have been approved in infants, but some of them are poorly tolerated. Oral ivermectin is approved for the treatment of scabies in several countries, but its use in infants and children weighing < 15 kg is off label.

OBJECTIVES: To assess the safety of ivermectin in infants and young children, and to collect data on ivermectin efficacy in these age groups.

METHODS: This study was performed in ...

Kjent for Scabies Infants |  ivermectin children |  oral administration |  weighing 15 |  topical treatment
KOL Index score: 12310

INTRODUCTION: Several studies have shown a high prevalence of cardiovascular and metabolic comorbidities in psoriasis. Our study aimed to evaluate the association of psoriasis with key comorbidities such as smoking, obesity, hypertension, dyslipidaemia and diabetes comparatively with French national data.

MATERIAL AND METHODS: This multicentre noninterventional observational study of adults with psoriasis was conducted in 29 dermatology centres in France. A total of 2210 patients were ...

Kjent for Psoriasis Patients |  prevalence comorbidities |  obesity hypertension |  age onset |  psoriatic arthritis
KOL Index score: 11861

BACKGROUND: Few prospective studies are available on the incidence and analysis of the characteristics of adverse cutaneous drug reactions in hospital settings.

OBJECTIVES: A 6-month prospective study was managed in our hospital among hospitalized patients to: (i) evaluate the incidence of cutaneous allergic reactions from systemic drugs; (ii) study characteristics of patients with cutaneous drug reactions; (iii) describe the adverse cutaneous reactions; and (iv) evaluate drug reaction ...

Kjent for Drug Reactions |  hospitalized patients |  adverse cutaneous |  15 cases |  hospital setting
KOL Index score: 10400

BACKGROUND: Psoriasis is associated with higher prevalences of cardiovascular and metabolic comorbidities in adults but the relationship of age at onset and those prevalences is unknown.

OBJECTIVE: To evaluate whether the childhood onset of psoriasis (COP) is correlated with the frequency of cardiovascular and metabolic comorbidities in adulthood.

METHODS: This noninterventional, cross-sectional, multicentre study of adults with psoriasis was conducted in 29 dermatology centres in ...

Kjent for Onset Psoriasis |  metabolic comorbidities |  dyslipidaemia diabetes |  waist circumference |  cardiovascular risk
KOL Index score: 9853

BACKGROUND: Dupilumab is the first biologic available to treat atopic dermatitis (AD). Its effectiveness and safety were demonstrated in clinical trials.

OBJECTIVE: We sought to assess the effectiveness and safety of dupilumab in adults with AD in a real-life French multicenter retrospective cohort.

METHODS: We included patients treated during March 2017-April 2018. Efficacy outcomes, including Scoring Atopic Dermatitis (SCORAD) and Eczema Area and Severity Index (EASI) scores, were ...

Kjent for Atopic Dermatitis |  monoclonal antibodies |  safety dupilumab |  adult cohort |  3 months
KOL Index score: 9790

BACKGROUND: Psoriasis is a T-cell-mediated immunological disease characterized by epidermal proliferation. The nature of the antigen(s) responsible for T-cell activation is still unknown. It has been suggested that the human papillomaviruses (HPVs) associated with epidermodysplasia verruciformis (EV), including the oncogenic HPV5, may contribute to the pathogenesis of psoriasis.

OBJECTIVES: To determine whether EV-HPVs may play a role early in the disease, we searched for these viruses ...

Kjent for Epidermodysplasia Verruciformis |  human papillomaviruses |  atopic dermatitis |  hpv5 hpv36 |  pathogenesis psoriasis
KOL Index score: 9235

BACKGROUND: Sirolimus is an immunosuppressive drug recently developed for organ transplantation. Its mechanism of action, independent of calcineurin, is different from that of cyclosporine and tacrolimus, two calcineurin inhibitors (CIs). Because the toxicity of CIs is partly the result of calcineurin blockade, sirolimus exhibits a different toxicity profile. In this study, we evaluated the profile, frequency, and severity of cutaneous adverse events in renal transplant recipients ...

Kjent for Renal Transplant Recipients |  cutaneous adverse events |  receiving sirolimus |  immunosuppressive agents kidney |  organ transplantation
KOL Index score: 9121

BACKGROUND: Obesity is more common in adults with psoriasis than in the general population, but there is a lack of data available regarding this association in children.

OBJECTIVES: To evaluate whether obesity was more common in French children with psoriasis of any clinical type or severity.

METHODS: A multicentre case-control study was performed in 23 French dermatology centres. Children without chronic or genetic inflammatory disease were selected as controls and matched for age, sex ...

Kjent for Children Psoriasis |  multicentre study |  overweight obesity |  chronic disease |  clinical type
KOL Index score: 9121

BACKGROUND: Excessive ultraviolet (UV) radiation exposure can cause skin cancers, skin photoageing and cataracts. Children are targeted by sun-protection campaigns because high sun exposure and sunburn in childhood increase the risk of melanoma in adulthood. Little information is available about UV radiation risk and exposure in children who take part in outdoor sports.

OBJECTIVE: To evaluate the risk of developing UV radiation-induced skin lesions run by children who practise outdoor ...

Kjent for Outdoor Sports |  uv radiation |  skin lesions |  sun exposure |  minimal erythema dose
KOL Index score: 8933

BACKGROUND: Age of the patients and age of onset of psoriasis may have an impact on the disease. There is little information about psoriasis in elderly patients.

OBJECTIVE: We evaluated epidemiological, clinical aspects, comorbidities and treatments of psoriasis in the elderly (>70 years) patients, and in patients with very late onset psoriasis (onset ≥ 70 years).

METHODS: This observational multicentre non-interventional study of adults with psoriasis was conducted in 29 departments of ...

Kjent for Onset Psoriasis |  elderly patients |  clinical aspects |  female france |  higher frequency
KOL Index score: 8610

INTRODUCTION: Psoriasis is associated with a higher risk of cardiovascular and/or metabolic comorbidity in adults, but discordant data have been reported in children.

OBJECTIVE: To evaluate the frequency of metabolic and cardiovascular comorbidity in children with psoriasis and to establish whether age at onset of psoriasis correlates with metabolic and cardiovascular comorbidity in adulthood.

MATERIAL AND METHODS: We conducted a systematic review on MEDLINE, using PubMed and Ovid. The ...

Kjent for Children Psoriasis |  obesity hypertension |  metabolic comorbidities |  cardiovascular risk |  diseases child
KOL Index score: 8507

Association of drug-induced hypersensitivity syndrome with viral infection is debated. Human herpesvirus 6 (HHV-6) reactivation has been the most frequently reported infection associated with this syndrome. However, a case of cytomegalovirus (CMV) infection was recently described associated with anticonvulsant-induced hypersensitivity syndrome. We report a case of severe allopurinol-induced hypersensitivity syndrome with pancreatitis associated with Epstein-Barr virus (EBV) infection. ...

Kjent for Hypersensitivity Syndrome |  barr virus |  ebv infection |  hhv6 dna |  drug induced
KOL Index score: 8352

BACKGROUND/OBJECTIVES: Little information is available on the prevalence and clinical aspects of nail involvement in children with psoriasis. The objective of this study was to evaluate the prevalence and clinical aspects of and the risk factors for nail involvement in French children with psoriasis.

METHODS: We performed a multicenter, cross-sectional study in 23 French dermatology centers. All children seen during the 1-year study were systematically included. Clinical features of the ...

Kjent for Nail Psoriasis |  313 children |  clinical aspects |  psoriatic arthritis |  background objectives
KOL Index score: 8209

There is a known relationship between the use of immunosuppressive therapies and the development of lymphoproliferative malignancies. These lymphomas are mainly B-cell nonHodgkin's lymphomas associated with Epstein-Barr virus. Most cases concern classical immunosuppressive treatments including ciclosporin and methotrexate. A relationship between the new antitumour necrosis factor (TNF)-alpha agents and lymphoproliferative malignancies is debated. Patients with psoriasis on ...

Kjent for Cell Lymphoma |  patients psoriasis |  immunosuppressive therapies |  lymphoproliferative malignancies |  anti tnf

Nøkkelpersoner for Children Psoriasis

Toppkols i verden
#1
Amy * ******
atopic dermatitis pediatric patients epidermolysis bullosa
#2
Matthias ********
chronic wounds atopic dermatitis skin diseases
#3
Kristian *****
plaque psoriasis psoriatic arthritis monoclonal antibodies
#4
Alan * ******
psoriatic arthritis monoclonal antibodies patients psoriasis
#5
Enno ************
atopic dermatitis human skin dermal fibroblasts
#6
Alice ****** ********
psoriatic arthritis monoclonal antibodies patients psoriasis

Emmanuel Mahé:Ekspertvirkning

Konsepter somEmmanuel Mahéhar direkte innflytelse:Children psoriasis,  Onset psoriasis,  Drug survival,  Pyoderma gangrenosum,  Psoriasis children,  Psoriasis severity,  Severe psoriasis,  Simplified psoriasis.

Emmanuel Mahé:Kol Impact

Konsepter relatert til arbeidet til andre forfattere somfor which Emmanuel Mahé har innflytelse:Atopic dermatitis,  Skin cancer,  Pediatric psoriasis,  Drug reaction,  Systemic symptoms,  Psoriatic arthritis,  Subcutaneous fat necrosis.


 

Tools

Er dette profilen din? manage_accounts Krev profilen din content_copy Kopier url code Legg inn lenke til profilen din


Dermatology Department, Centre Hospitalier (CH), Argenteuil, France | Hôpital Victor Dupouy, Dermatologie, Argenteuil, France | Service de Dermatologie, Hôpital Victor Dupouy, Argenteuil, France | Department of Dermatology, Victor Dupouy Hospital, Ar